PNC Financial Services Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.98M | Sell |
|
|||||
|
2025
Q2 | $4.29M | Buy |
|
|||||
|
2025
Q1 | $3.54M | Buy |
|
|||||
|
2024
Q4 | $2.95M | Sell |
|
|||||
|
2024
Q3 | $3.45M | Buy |
|
|||||
|
2024
Q2 | $3.01M | Buy |
|
|||||
|
2024
Q1 | $1.82M | Sell |
|
|||||
|
2023
Q4 | $2.51M | Sell |
|
|||||
|
2023
Q3 | $2.77M | Sell |
|
|||||
|
2023
Q2 | $2.98M | Buy |
|
|||||
|
2023
Q1 | $3.13M | Buy |
|
|||||
|
2022
Q4 | $3.7M | Sell |
|
|||||
|
2022
Q3 | $3.16M | Sell |
|
|||||
|
2022
Q2 | $2.39M | Buy |
|
|||||
|
2022
Q1 | $2.53M | Buy |
|
|||||
|
2021
Q4 | $2.63M | Buy |
|
|||||
|
2021
Q3 | $2.93M | Sell |
|
|||||
|
2021
Q2 | $2.71M | Buy |
|
|||||
|
2021
Q1 | $2.25M | Buy |
|
|||||
|
2020
Q4 | $1.87M | Buy |
|
|||||
|
2020
Q3 | $883K | Sell |
|
|||||
|
2020
Q2 | $1.01M | Sell |
|
|||||
|
2020
Q1 | $1.45M | Buy |
|
|||||
|
2019
Q4 | $1.04M | Buy |
|
|||||
|
2019
Q3 | $721K | Buy |
|
|||||
|
2019
Q2 | $643K | Buy |
|
|||||
|
2019
Q1 | $820K | Buy |
|
|||||
|
2018
Q4 | $635K | Buy |
|
|||||
|
2018
Q3 | $758K | Buy |
|
|||||
|
2018
Q2 | $852K | Sell |
|
|||||
|
2018
Q1 | $1.05M | Sell |
|
|||||
|
2017
Q4 | $1.13M | Buy |
|
|||||
|
2017
Q3 | $1.03M | Sell |
|
|||||
|
2017
Q2 | $739K | Buy |
|
|||||
|
2017
Q1 | $446K | Buy |
|
|||||
|
2016
Q4 | $322K | Sell |
|
|||||
|
2016
Q3 | $595K | Hold |
|
|||||
|
2016
Q2 | $487K | Buy |
|
|||||
|
2016
Q1 | $523K | Hold |
|
|||||
|
2015
Q4 | $782K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $14K | Hold |
|
|||||
|
2014
Q2 | $11K | Hold |
|
|||||
|
2014
Q1 | $12K | Buy |
|